NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019

Samir Gupta(University of California San Diego), Ndiya Ogba(National Comprehensive Cancer Network), Michael J. Hall(Fox Chase Cancer Center), Heather Hampel(City of Hope), June Mikkelson(University of Colorado Cancer Center), Arnold J. Markowitz(Memorial Sloan Kettering Cancer Center), Gregory S. Cooper(University Hospitals Case Medical Center), Amy L. Halverson(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Xavier Llor(Yale Cancer Center), Reid M. Ness(Breast Cancer Research Foundation), Thomas P. Slavin(City Of Hope National Medical Center), Robert J. Mayer(Applied Natural Sciences), Patrick M. Lynch(The University of Texas MD Anderson Cancer Center), Shajan Peter(University of Colorado Cancer Center), Dawn Provenzale(Michael E. DeBakey VA Medical Center), William M. Grady(Seattle University), Sigurdís Haraldsdóttir(Stanford University), Scott E. Regenbogen(Twitter (United States)), Dennis J. Ahnen(University of Colorado Denver), Stanley R. Hamilton(City of Hope), Daniel C. Chung(Massachusetts General Hospital), Francis M. Giardiello, Jason Klapman(Susan Thompson Buffett Foundation), Audrey J. Lazenby(University of Nebraska Medical Center), Dayna S. Early(Washington University in St. Louis), Mary A. Dwyer(National Comprehensive Cancer Network), Jennifer M. Weiss(University of Wisconsin–Madison), Lee-may Chen(UCSF Helen Diller Family Comprehensive Cancer Center), Priyanka Kanth(University of Utah)
Journal of the National Comprehensive Cancer Network
September 1, 2019
Cited by 342


Related Papers